Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Athanasios D Anastasilakis

Showing results (21-30 of 156) with videos related to

Pageof 16
Sort By:
Endocrine Connections|July 4, 2018
Bone metabolism in Langerhans cell histiocytosisAthanasios D Anastasilakis, Marina Tsoli, Gregory Kaltsas, et al.
Expert Opinion on Investigational Drugs|October 16, 2014
Investigational parathyroid hormone receptor analogs for the treatment of osteoporosisStergios A Polyzos, Polyzois Makras, Zoe Efstathiadou, et al.
Bone|August 28, 2019
Off-label uses of denosumab in metabolic bone diseasesStergios A Polyzos, Polyzois Makras, Symeon Tournis, et al.
Journal of Musculoskeletal & Neuronal Interactions|March 4, 2021
Zoledronic acid is effective in the management of migratory osteoporosis unresponsive to conservative treatment and risedronate: A case reportGerasimos Evangelatos, George E Fragoulis, Athanasios D Anastasilakis, et al.
Hormones (Athens, Greece)|August 29, 2007
Oral bisphosphonate adverse effects in 849 patients with metabolic bone diseasesAthanasios D Anastasilakis, Dimitrios G Goulis, Marina Kita, et al.
Hormones (Athens, Greece)|June 8, 2018
Hypoparathyroidism: is it that easy to treat?Evangelia Triantafyllou, Maria P Yavropoulou, Athanasios D Anastasilakis, et al.
Diabetes, Obesity & Metabolism|June 24, 2025
The effects of anti-obesity medications on bone metabolism: A critical appraisalAthanasios D Anastasilakis, Julien Paccou, Andrea Palermo, et al.
Arquivos Brasileiros De Endocrinologia E Metabologia|September 22, 2010
Primary hyperparathyroidism and incidental multifocal metastatic papillary thyroid carcinoma in a manStergios A Polyzos, Athanasios D Anastasilakis, Ioannis P Iakovou, et al.
Calcified Tissue International|August 3, 2023
The Five-Year Effect of a Single Zoledronate Infusion on Bone Mineral Density Following Denosumab Discontinuation in Women with Postmenopausal OsteoporosisAthanasios D Anastasilakis, Polyzois Makras, Stergios A Polyzos, et al.
Joint Bone Spine|July 3, 2023
Risk and management of osteoporosis due to inhaled, epidural, intra-articular or topical glucocorticoidsAthanasios D Anastasilakis, Anda Mihaela Naciu, Maria P Yavropoulou, et al.
Pageof 16

Showing results (21-30 of 156) with videos related to

Sort By:
Pageof 16
Endocrine Connections|July 4, 2018
Bone metabolism in Langerhans cell histiocytosisAthanasios D Anastasilakis, Marina Tsoli, Gregory Kaltsas, et al.
Expert Opinion on Investigational Drugs|October 16, 2014
Investigational parathyroid hormone receptor analogs for the treatment of osteoporosisStergios A Polyzos, Polyzois Makras, Zoe Efstathiadou, et al.
Bone|August 28, 2019
Off-label uses of denosumab in metabolic bone diseasesStergios A Polyzos, Polyzois Makras, Symeon Tournis, et al.
Journal of Musculoskeletal & Neuronal Interactions|March 4, 2021
Zoledronic acid is effective in the management of migratory osteoporosis unresponsive to conservative treatment and risedronate: A case reportGerasimos Evangelatos, George E Fragoulis, Athanasios D Anastasilakis, et al.
Hormones (Athens, Greece)|August 29, 2007
Oral bisphosphonate adverse effects in 849 patients with metabolic bone diseasesAthanasios D Anastasilakis, Dimitrios G Goulis, Marina Kita, et al.
Hormones (Athens, Greece)|June 8, 2018
Hypoparathyroidism: is it that easy to treat?Evangelia Triantafyllou, Maria P Yavropoulou, Athanasios D Anastasilakis, et al.
Diabetes, Obesity & Metabolism|June 24, 2025
The effects of anti-obesity medications on bone metabolism: A critical appraisalAthanasios D Anastasilakis, Julien Paccou, Andrea Palermo, et al.
Arquivos Brasileiros De Endocrinologia E Metabologia|September 22, 2010
Primary hyperparathyroidism and incidental multifocal metastatic papillary thyroid carcinoma in a manStergios A Polyzos, Athanasios D Anastasilakis, Ioannis P Iakovou, et al.
Calcified Tissue International|August 3, 2023
The Five-Year Effect of a Single Zoledronate Infusion on Bone Mineral Density Following Denosumab Discontinuation in Women with Postmenopausal OsteoporosisAthanasios D Anastasilakis, Polyzois Makras, Stergios A Polyzos, et al.
Joint Bone Spine|July 3, 2023
Risk and management of osteoporosis due to inhaled, epidural, intra-articular or topical glucocorticoidsAthanasios D Anastasilakis, Anda Mihaela Naciu, Maria P Yavropoulou, et al.
Pageof 16